ZZQ PeptidesGHK-Cu
Ordered GHK-Cu from ZZQ Peptides? Mail in a sample (US only) and let us test it for free.
Test my supplyZZQ Peptides' GHK-Cu profile is dragged down by a Jan 2026 fill outlier: 27.2 mg tested against a 10 mg claim (+172%). Later tests recovered with passing identity and high purity, but early batch-ID gaps leave a less clean evidence trail.
We investigated who actually operates ZZQ Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including ZZQ Peptides rows.
Cancel anytime
About ZZQ Peptides test results from Finnrick
ZZQ Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 51 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible ZZQ Peptides peptides in this dataset are Cagrilintide (3 tests), GHK-Cu (6 tests) and Retatrutide (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 51 recent tests.
Ordered GHK-Cu from ZZQ Peptides? Mail in a sample (US only) and let us test it for free.
Test my supply